Locoregional chemotherapy in pancreatic cancer

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 479-482

  Nazli, Okay ^a,b   Tansug, Tugrul ^a   Bozdag, Ali Dogan ^a   Cln, Necat ^a   Kaymak, Erol ^a  

^a Third Surg Clin of Ataturk T H   (Turkey)

^b Halide Edip Adyvar Cad   (Turkey)

Author keywords

Advanced stage pancreatic cancer; Locoregional chemotherapy; Pancreatic cancer

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CELIAC ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LAPAROTOMY; MALE; PALLIATIVE THERAPY; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; CARCINOMA; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032997262     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. 1 Unal AE, Atabekoglu S, Kocaoglu H: Exocrine tumors of the pancreas. Klinik Cerrahi Onkoloji 1997; 36:488-495.
2. 2 Aigner KR: Methodische Ansatze zur optimierung des Konzentration - Zeit Faktors in der regionalen chemoterapie. In: Seeberger S, et al (Hrsg.). Onkologisches Kollogium 2. Die Lokoregionele Tumortherapie moglichkeiten und Grenzen. Berlin, 1988; pp. 2-11.
3. 3 Formentini A, Link KH: Neoadjuvant regional chemotherapy for nonresectable pancreatic and hepatic tumors. Regional Cancer Treatment 1997; Suppl 1:60-68.
4. 4 Aigner KR, Gailhofer S: Celiac axis stopflow infusion and abdominal perfusion for stage III/IV pancreatic cancer. 8. International Conference of Regional Cancer Treatment, Abstracts 1997; pp. 6-10.
5. 5 Lygidakis NJ, Dedemadi G, Spentzouris N, Theodoropoulou M: Unresectable pancreatic cancer: is a multi-modality approach a promising therapeutic alternative? Hepato-Gastroenterol 1997; 44:1222-1228.
6. 6 Nagai H, Kuroda A, Morioka Y: Lymphatic and local spread of T1 and T2 pancreatic cancer. Ann Surg 1986; 204:65.
7. 7 Bodner E: Intraoperative bestrahlung beim pankreas carcinom. Chirurg 1994, 65:241-245.
8. 8 Tepper J, Nardi G, Suit H: Carcinoma of the pancreas. Review of MGH experience from 1963 to 1973. Cancer 1976; 37:1519-1524.
9. 9 Griffin JF, Smalley SR, Jewel W, et al: Patterns of failure of curative resection of pancreas carcinoma. Cancer 1990; 66:56-61.
10. 10 Gansouge F, Link KH, Formentini A, et al: Palliative and adjuvant regional chemotherapy in pancreatic cancer seems to double median survival times. 8. International conference of regional cancer treatment, Abstracts 1997; pp. 60-63.
11. 11 Beger HG, Link KH, Poch B, Gansouge F: Pancreatic cancer - recent progress in diagnosis and treatment. In: Neoptolemos JP, Lemoin NR (Eds.). Pancreatic cancer. Molecular and clinical advances. Blackwell, Oxford, 1996 18:358-375.
12. 12 Beger HG, Bucher MW, Fries H: Chirurgische ergebnisse und endikation zu adjuvan massnahmen beim pankreas carcinom. Chirurg 1994; 4:246-253.
13. 13 Klapdor R, Lang-Polkow E, et al: Intraarterielle lokale systemische chemotherapie des fortgeschrittenen metastasierenden pankreas karzinom bei sieben patienten. Deutsche Krebsgesellschaft eV. 1997; 12:408-409.
14. 14 Blatzas G, Chataigeargiu G, et al: Regional chemotherapy for nonresectable pancreatic cancer. 8. International conference of regional cancer treatment. Abstracts 1997; pp. 68.
15. 15 Fiorentini D, Poddi S, Ricci M, et al: Locoregional chemotherapy with (MMC) administered as intraaortic stopflow infusion with hipoxic abdominal perfusion in UICC stage III-IV pancreatic carcinoma. 8. International conference of regional cancer treatment. Abstracts 1997; pp. 51-61.